About
Butterfly Medical is a medical device company focused on developing a minimally invasive implantable device for treating Benign Prostatic Hyperplasia (BPH). Founded in late 2014 and led by entrepreneur Yehuda Bachar, the company aims to offer a new generation of BPH treatment that avoids cutting, burning, or removing tissue. Their flagship product provides a procedure that retracts the lateral lobes of the prostate without causing tissue damage and is fully reversible. The company has achieved CE Mark approval in Europe and is currently advancing its treatment through clinical trials and patient education. Butterfly Medical targets men experiencing BPH symptoms, healthcare providers specializing in urology, and medical institutions looking for less invasive treatment options. Their innovative approach addresses the quality-of-life impact of BPH, which affects millions of men worldwide.
Technologies
Keywords
Company Information
-
Employees 21
-
Founded 2014
-
Annual Revenue $7500000
-
Total Funding $9000000
Location
4 А-Тавор, Yokne'am Illit, North District, Israel, 20692